Modular antibodies reveal DNA damage-induced mono-ADP-ribosylation as a second wave of PARP1 signaling.


Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
18 05 2023
Historique:
received: 10 10 2022
revised: 14 02 2023
accepted: 27 03 2023
medline: 22 5 2023
pubmed: 29 4 2023
entrez: 28 4 2023
Statut: ppublish

Résumé

PARP1, an established anti-cancer target that regulates many cellular pathways, including DNA repair signaling, has been intensely studied for decades as a poly(ADP-ribosyl)transferase. Although recent studies have revealed the prevalence of mono-ADP-ribosylation upon DNA damage, it was unknown whether this signal plays an active role in the cell or is just a byproduct of poly-ADP-ribosylation. By engineering SpyTag-based modular antibodies for sensitive and flexible detection of mono-ADP-ribosylation, including fluorescence-based sensors for live-cell imaging, we demonstrate that serine mono-ADP-ribosylation constitutes a second wave of PARP1 signaling shaped by the cellular HPF1/PARP1 ratio. Multilevel chromatin proteomics reveals histone mono-ADP-ribosylation readers, including RNF114, a ubiquitin ligase recruited to DNA lesions through a zinc-finger domain, modulating the DNA damage response and telomere maintenance. Our work provides a technological framework for illuminating ADP-ribosylation in a wide range of applications and biological contexts and establishes mono-ADP-ribosylation by HPF1/PARP1 as an important information carrier for cell signaling.

Identifiants

pubmed: 37116497
pii: S1097-2765(23)00240-X
doi: 10.1016/j.molcel.2023.03.027
pmc: PMC10205078
pii:
doi:

Substances chimiques

Histones 0
Poly (ADP-Ribose) Polymerase-1 EC 2.4.2.30
Chromatin 0
Antibodies 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1743-1760.e11

Subventions

Organisme : NCI NIH HHS
ID : R01 CA262316
Pays : United States
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R007195/1
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA207209
Pays : United States
Organisme : Cancer Research UK
ID : C35050/A22284
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 101794
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 210634
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P30 CA047904
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM133332
Pays : United States

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests E.J.L., H.D., J.J.B., T.C., and I.M. declare the following competing financial interests: Max-Planck-Innovation, the technology transfer center of the Max Planck Society, has licensed the antibodies AbD33204, AbD33205, AbD33644, AbD34251, AbD33641, and AbD43647 to Bio-Rad Laboratories.

Références

Org Biomol Chem. 2019 Jun 5;17(22):5460-5474
pubmed: 31112180
Cell. 2020 Nov 12;183(4):1086-1102.e23
pubmed: 33186521
Mol Cell. 2021 Jun 17;81(12):2640-2655.e8
pubmed: 34019811
Nat Commun. 2017 Dec 12;8(1):2055
pubmed: 29234005
Nature. 2021 Aug;596(7873):597-602
pubmed: 34408320
Nat Biotechnol. 2015 Apr;33(4):384-9
pubmed: 25774713
Mol Cell Proteomics. 2002 May;1(5):376-86
pubmed: 12118079
Nucleic Acids Res. 2011 Aug;39(15):6475-88
pubmed: 21576221
Cell Rep. 2018 Aug 28;24(9):2493-2505.e4
pubmed: 30157440
Elife. 2018 Feb 26;7:
pubmed: 29480802
Cancer Commun (Lond). 2021 Feb;41(2):187-191
pubmed: 33417305
Nat Struct Mol Biol. 2013 Apr;20(4):508-14
pubmed: 23474712
Nat Commun. 2021 Oct 8;12(1):5893
pubmed: 34625544
J Mol Biol. 2011 Oct 14;413(1):261-78
pubmed: 21856311
Cell Death Differ. 2013 Aug;20(8):1055-67
pubmed: 23645206
Nat Chem Biol. 2018 Feb 14;14(3):236-243
pubmed: 29443986
J Vis Exp. 2021 Jun 1;(172):
pubmed: 34152325
Cell Rep. 2021 Nov 2;37(5):109917
pubmed: 34731617
Nat Chem Biol. 2016 Dec;12(12):998-1000
pubmed: 27723750
Mol Cell. 2022 Jun 16;82(12):2315-2334
pubmed: 35271815
J Am Chem Soc. 2021 Jul 28;143(29):10847-10852
pubmed: 34264659
CRISPR J. 2022 Feb;5(1):123-130
pubmed: 35119294
Cell Rep. 2019 Jan 22;26(4):955-968.e3
pubmed: 30673617
Elife. 2021 Dec 07;10:
pubmed: 34874266
J Am Chem Soc. 2015 Mar 18;137(10):3558-64
pubmed: 25706250
Nucleic Acids Res. 2019 Dec 2;47(21):11250-11267
pubmed: 31566235
Mol Cell. 2021 Jan 21;81(2):340-354.e5
pubmed: 33450210
Science. 2009 Sep 4;325(5945):1240-3
pubmed: 19661379
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Mol Gen Genet. 1995 Jan 6;246(1):10-8
pubmed: 7823904
Mol Cell. 2018 Oct 4;72(1):162-177.e7
pubmed: 30244833
ACS Chem Biol. 2022 Apr 15;17(4):810-815
pubmed: 35312285
Science. 2011 Jun 17;332(6036):1443-6
pubmed: 21680843
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Sci Adv. 2022 Oct 7;8(40):eadd4253
pubmed: 36197986
J Am Chem Soc. 2021 Mar 3;143(8):3037-3042
pubmed: 33596067
Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):E690-7
pubmed: 22366317
Genome Biol. 2003;4(5):P3
pubmed: 12734009
Mol Cell. 2021 Nov 4;81(21):4552-4567.e8
pubmed: 34551281
Genes Dev. 1998 Dec 15;12(24):3831-42
pubmed: 9869637
Nat Commun. 2020 Jul 7;11(1):3391
pubmed: 32636369
Nat Commun. 2021 Nov 18;12(1):6675
pubmed: 34795260
Cell. 2010 Oct 29;143(3):470-84
pubmed: 21029866
J Biol Chem. 2011 Dec 9;286(49):42470-42482
pubmed: 22027841
Methods Mol Biol. 2011;780:209-26
pubmed: 21870263
Nucleic Acids Res. 2017 Aug 21;45(14):8129-8141
pubmed: 28854736
Am J Hum Genet. 2018 Sep 6;103(3):431-439
pubmed: 30100084
Nature. 2020 Mar;579(7800):598-602
pubmed: 32028527
Biochemistry. 2017 Dec 5;56(48):6305-6316
pubmed: 29053245
Nature. 2008 Jan 3;451(7174):81-5
pubmed: 18172500
Mol Cell. 2017 Mar 2;65(5):932-940.e6
pubmed: 28190768
Mol Cell. 2017 May 18;66(4):503-516.e5
pubmed: 28525742
Science. 2016 Jul 1;353(6294):45-50
pubmed: 27256882
Nat Commun. 2014 Jul 21;5:4426
pubmed: 25043379
Nat Commun. 2020 Oct 15;11(1):5199
pubmed: 33060572
Nat Commun. 2019 Jul 4;10(1):2954
pubmed: 31273204
Elife. 2017 Jun 26;6:
pubmed: 28650317
Life Sci Alliance. 2021 Sep 3;4(11):
pubmed: 34479984
J Cell Biol. 2021 Apr 5;220(4):
pubmed: 33570569
Nat Rev Mol Cell Biol. 2014 Jan;15(1):7-18
pubmed: 24326623
Nat Struct Mol Biol. 2023 May;30(5):678-691
pubmed: 37106138
Elife. 2022 Apr 27;11:
pubmed: 35476036
Cell Chem Biol. 2021 Jun 17;28(6):813-824.e6
pubmed: 33529581
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Am J Hum Genet. 2018 Nov 1;103(5):817-825
pubmed: 30401461
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2006 Mar 1;62(Pt 3):224-7
pubmed: 16511307
Mol Immunol. 2008 Nov;46(1):135-44
pubmed: 18722015
Nucleic Acids Res. 2019 Jul 2;47(W1):W171-W174
pubmed: 31106371
Mol Cell. 2016 May 5;62(3):432-442
pubmed: 27067600
Proc Natl Acad Sci U S A. 2022 Mar 15;119(11):e2121979119
pubmed: 35259019
Cell. 2014 Sep 25;159(1):108-121
pubmed: 25259924
Genes Dev. 2017 Jan 15;31(2):101-126
pubmed: 28202539
Cell. 2006 Jan 27;124(2):315-29
pubmed: 16439206

Auteurs

Edoardo José Longarini (EJ)

Research Group of Proteomics and ADP-Ribosylation Signaling, Max Planck Institute for Biology of Ageing, 50931 Cologne, Germany.

Helen Dauben (H)

Research Group of Proteomics and ADP-Ribosylation Signaling, Max Planck Institute for Biology of Ageing, 50931 Cologne, Germany.

Carolina Locatelli (C)

Research Group of Proteomics and ADP-Ribosylation Signaling, Max Planck Institute for Biology of Ageing, 50931 Cologne, Germany.

Anne R Wondisford (AR)

Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.

Rebecca Smith (R)

Univ Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, BIOSIT (Biologie, Santé, Innovation Technologique de Rennes) - UMS 3480, US 018, 35000 Rennes, France.

Charlotte Muench (C)

Research Group of Proteomics and ADP-Ribosylation Signaling, Max Planck Institute for Biology of Ageing, 50931 Cologne, Germany.

Andreas Kolvenbach (A)

Research Group of Proteomics and ADP-Ribosylation Signaling, Max Planck Institute for Biology of Ageing, 50931 Cologne, Germany.

Michelle Lee Lynskey (ML)

Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.

Alexis Pope (A)

Research Group of Proteomics and ADP-Ribosylation Signaling, Max Planck Institute for Biology of Ageing, 50931 Cologne, Germany.

Juan José Bonfiglio (JJ)

Research Group of Proteomics and ADP-Ribosylation Signaling, Max Planck Institute for Biology of Ageing, 50931 Cologne, Germany.

Eva Pinto Jurado (EP)

Univ Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, BIOSIT (Biologie, Santé, Innovation Technologique de Rennes) - UMS 3480, US 018, 35000 Rennes, France; Laboratory of DNA Damage and Nuclear Dynamics, Institute of Genetics, Biological Research Centre, Eötvös Loránd Research Network (ELKH), 6276 Szeged, Hungary; Doctoral School of Multidisciplinary Medical Sciences, University of Szeged, 6276 Szeged, Hungary.

Roberta Fajka-Boja (R)

Laboratory of DNA Damage and Nuclear Dynamics, Institute of Genetics, Biological Research Centre, Eötvös Loránd Research Network (ELKH), 6276 Szeged, Hungary; Department of Immunology, Albert Szent-Györgyi Medical School, Faculty of Science and Informatics, University of Szeged, 6720 Szeged, Hungary.

Thomas Colby (T)

Research Group of Proteomics and ADP-Ribosylation Signaling, Max Planck Institute for Biology of Ageing, 50931 Cologne, Germany.

Marion Schuller (M)

Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.

Ivan Ahel (I)

Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.

Gyula Timinszky (G)

Laboratory of DNA Damage and Nuclear Dynamics, Institute of Genetics, Biological Research Centre, Eötvös Loránd Research Network (ELKH), 6276 Szeged, Hungary.

Roderick J O'Sullivan (RJ)

Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.

Sébastien Huet (S)

Univ Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, BIOSIT (Biologie, Santé, Innovation Technologique de Rennes) - UMS 3480, US 018, 35000 Rennes, France; Institut Universitaire de France, Paris, France. Electronic address: sebastien.huet@univ-rennes.fr.

Ivan Matic (I)

Research Group of Proteomics and ADP-Ribosylation Signaling, Max Planck Institute for Biology of Ageing, 50931 Cologne, Germany; Cologne Excellence Cluster for Stress Responses in Ageing-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany. Electronic address: imatic@age.mpg.de.

Articles similaires

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.

Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli et al.
1.00
Humans Multiple Myeloma Receptors, Fibroblast Growth Factor Fibroblast Growth Factors Proto-Oncogene Proteins c-myc
Animals Lung India Sheep Transcriptome

Calcineurin inhibition enhances

Priyanka Das, Alejandro Aballay, Jogender Singh
1.00
Animals Caenorhabditis elegans Longevity Caenorhabditis elegans Proteins Calcineurin
1.00
Animals Mice Immunity, Innate Interneurons Synapses

Classifications MeSH